RSS   Newsletter   Contact   Advertise with us

Australia provisionally approves AstraZeneca's COVID-19 vaccine as booster dose

Reading time 1 min     Christian Fernsby ▼ | February 10, 2022
On 8 February 2022, the medical regulator the Therapeutic Goods Administration (TGA) provisionally approved a booster dose of the AstraZeneca COVID-19 vaccine, Vaxzevria, for individuals aged 18 years and older.
Greg Hunt
Australia   Greg Hunt
The third (booster) dose may be given if clinically indicated with reference to official guidance regarding the use of a heterologous third dose (e.g. mRNA vaccine).

Topics: Australia

This means that the decision to receive Vaxzevria as a booster must be made in consultation with a medical professional. The mRNA COVID-19 vaccines (Comirnaty (Pfizer) or Spikevax (Moderna) are preferred as the booster dose in Australia, irrespective of the primary COVID-19 vaccine used. This includes for people who received the AstraZeneca COVID-19 vaccine for their primary course.

Minister for Health and Aged Care Greg Hunt said in a media release on Thursday that senior Australians in residential aged care are leading the national uptake of boosters, with 80.56 percent of those eligible for their third vaccine shot now having received it.

"The booster vaccination rate for aged care residents is well ahead of the national community figure of 55.43 percent," he said.


 

MORE INSIDE POST


 
 
 

U.S.: Heavy rain, flash and river flooding, strong to severe thunderstorms

Francine will continue to weaken today as its low pressure center meanders east across northern Arkansas.
 

NEWS

TRENDING

POLITICS

CAREERS

OP-ED

 
 

QUOTE OF THE MOMENT

Epicurus"The greater the difficulty, the more the glory in surmounting it."

Epicurus